Search Results

The Role of Sodium Channels in the Mechanism of Action of Antidepressants and Mood Stabilizers

Authors: Bourin, Michel; Chenu, Franck; Hascoet, Martine

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1052-1060(9)

Publisher: Bentham Science Publishers

Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors

Authors: Guiard, Bruno P.; Mansari, Mostafa E.; Blier, Pierre

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1069-1084(16)

Publisher: Bentham Science Publishers

Emerging drugs for insomnia: new frontiers for old and novel targets

Authors: Sullivan, Shannon S; Guilleminault, Christian

Source: Expert Opinion on Emerging Drugs, Volume 14, Number 3, September 2009 , pp. 411-422(12)

Publisher: Informa Healthcare

From Antidepressant Drugs to Beta-Mimetics: Preclinical Insights on Potential New Treatments for Neuropathic Pain

Authors: Barrot, Michel; Yalcin, Ipek; Choucair-Jaafar, Nada; Benbouzid, Malika; Freund-Mercier, Marie-Jose

Source: Recent Patents on CNS Drug Discovery, Volume 4, Number 3, November 2009 , pp. 182-189(8)

Publisher: Bentham Science Publishers

A Single-Blind Placebo Run-In Study of Venlafaxine XR for Activity-Limiting Osteoarthritis Pain

Authors: Sullivan, Mark; Bentley, Susan; Fan, Ming-Yu; Gardner, Greg

Source: Pain Medicine, Volume 10, Number 5, July/August 2009 , pp. 806-812(7)

Publisher: Blackwell Publishing

Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice

Authors: Biala, Grazyna; Kruk, Marta

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 4, April 2009 , pp. 493-502(10)

Publisher: Pharmaceutical Press

Editorial [Hot Topic: New Antidepressant Drugs: Beyond Monoaminergic Mechanisms (Executive Editors: Cecilio Alamo and Francisco Lopez-Munoz)]

Authors: Alamo, Cecilio; Lopez-Munoz, Francisco

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1559-1562(4)

Publisher: Bentham Science Publishers

Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today

Authors: Lopez-Munoz, Francisco; Alamo, Cecilio

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1563-1586(24)

Publisher: Bentham Science Publishers

Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models

Authors: Rodriguez Bambico, Francis; Duranti, Andrea; Tontini, Andrea; Tarzia, Giorgio; Gobbi, Gabriella

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1623-1646(24)

Publisher: Bentham Science Publishers

Melatonin Receptor Agonist Agomelatine: A New Drug for Treating Unipolar Depression

Authors: Bourin, Michel; Prica, Corina

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1675-1682(8)

Publisher: Bentham Science Publishers

New Approaches to Antidepressant Drug Design: Cytokine-Regulated Pathways

Authors: Nishida, Akira; Miyaoka, Tsuyoshi; Inagaki, Takuji; Horiguchi, Jun

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1683-1687(5)

Publisher: Bentham Science Publishers

Targeting the Hippocampal Mossy Fiber Synapse for the Treatment of Psychiatric Disorders

Author: Kobayashi, Katsunori

Source: Molecular Neurobiology, Volume 39, Number 1, February 2009 , pp. 24-36(13)

Publisher: Humana Press

Pharmacological treatment of refractory breathlessness

Authors: Booth, Sara; Bausewein, Claudia; Higginson, Irene; Moosavi, Shakeeb H

Source: Expert Review of Respiratory Medicine, Volume 3, Number 1, February 2009 , pp. 21-36(16)

Publisher: Expert Reviews

Downregulation of Ccnd1 and Hes6 in rat hippocampus after chronic exposure to the antidepressant paroxetine

Authors: McHugh, Patrick C.; Rogers, Geraldine R.; Glubb, Dylan M.; Allington, Melanie D.; Hughes, Mark; Joyce, Peter R.; Kennedy, Martin A.

Source: Acta Neuropsychiatrica, Volume 20, Number 6, December 2008 , pp. 307-313(7)

Publisher: Blackwell Publishing

Chronic Administration of Ketamine Elicits Antidepressant-Like Effects in Rats without Affecting Hippocampal Brain-Derived Neurotrophic Factor Protein Levels

Authors: Garcia, Lêda S.; Comim, Clarissa M.; Valvassori, Samira S.; Réus, Gislaine Z.; Andreazza, Ana Cristina; Stertz, Laura; Fries, Gabriel R.; Gavioli, Elaine Cristina; Kapczinski, Flavio; Quevedo, João

Source: Basic & Clinical Pharmacology & Toxicology, Volume 103, Number 6, December 2008 , pp. 502-506(5)

Publisher: Blackwell Publishing

Antidepressants for the Treatment of Insomnia: A Suitable Approach?

Author: Wiegand, Michael H.

Source: Drugs, Volume 68, Number 17, 2008 , pp. 2411-2417(7)

Publisher: Adis International

Antagonists at Metabotropic Glutamate Receptor Subtype 5: Structure Activity Relationships and Therapeutic Potential for Addiction

Author: Carroll, F. Ivy

Source: Annals of the New York Academy of Sciences, Volume 1141, Number 1, October 2008 , pp. 221-232(12)

Publisher: Blackwell Publishing

Upcoming Agents for the Treatment of Schizophrenia: Mechanism of Action, Efficacy and Tolerability

Authors: Bishara, Delia; Taylor, David

Source: Drugs, Volume 68, Number 16, 2008 , pp. 2269-2292(24)

Publisher: Adis International

Anticonvulsants - Antidepressants Pharmacokinetic Drug Interactions: The Role of the CYP450 System in Psychopharmacology

Author: Mula, Marco

Source: Current Drug Metabolism, Volume 9, Number 8, October 2008 , pp. 730-737(8)

Publisher: Bentham Science Publishers

Glutamate-Based Drugs for the Treatment of Clinical Depression

Authors: Leheste, J. R.; Curcio, C.; Baldinger, L.; Sarwar, S.; Zakhary, S. M.; Hallas, B. H.; Horowitz, J. M.; Torres, G.

Source: Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal, Volume 8, Number 3, September 2008 , pp. 170-176(7)

Publisher: Bentham Science Publishers